Veterinary Infectious Disease Diagnostics Market , by Product Type (Immunodiagnostics, Molecular Diagnostics, and Others) and Application (Dogs, Cats, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
- ALL3848254
- 206 Pages
- March 2020
- Healthcare
There are various types of infectious diseases, which affect companion animals. Furthermore, these diseases are fatal and can also lead to serious complications, if timely treatment is not provided. For instance, canine distemper is a common viral disease in dogs, which if left untreated lead to complications such as degeneration of the nervous system. Moreover, there are bacterial, parasitic and other type of infectious diseases as well that affect companion animals. The products used in procedures conducted to test the presence of infectious diseases in animals are known as veterinary infectious disease diagnostics. Moreover, there are different types of veterinary infectious disease diagnostics available in the market such as immunodiagnostics and molecular diagnostics. These are generally used to diagnose infectious diseases in animals such as cats and dogs.
Rise in ownership of companion animals and surge in animal health expenditure are the major factors that boost the veterinary infectious disease diagnostics growth of the global veterinary infectious disease diagnostics market. In addition, increase in prevalence of various infectious diseases among companion animals significantly drives the growth of the veterinary infectious disease diagnostics market. However, lack of awareness related to the use of veterinary infectious disease diagnostics in underdeveloped countries restricts the growth of the market. On the contrary, surge in awareness related to animal healthcare across the globe is expected to offer remunerative opportunities for market expansion during the forecast period.
The global veterinary infectious disease diagnostics market size is studied on the basis of product type, application, and region. On the basis of product type, it is segmented into immunodiagnostics, molecular diagnostics, and others. By application, it is classified into dogs, cats, and others. By region, it is analyzed across North America (the U.S, Canada, and Mexico) and Europe (Germany, France, Italy, the UK and rest of Europe), Asia-Pacific (Japan, China, India, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA). .
KEY BENEFITS FOR STAKEHOLDERS
• This report entails a detailed quantitative analysis along with the current global veterinary infectious disease diagnostics market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
• The market size and estimations are based on a comprehensive analysis of key developments in the industry.
• A qualitative analysis based on innovative products facilitates strategic business planning.
• The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
Key Market Segments
• By Product Type
o Immunodiagnostics
o Molecular Diagnostics
o Others
• By Application
o Dog
o Cat
o Others
• By Region
o North America
o U.S.
o Canada
o Mexico
o Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
o Asia-Pacific
o Japan
o China
o Australia
o Rest of Asia-Pacific
o LAMEA
o Brazil
o Saudi Arabia
o South Africa
Rest of LAMEA
List of key players profiled in the report:
• Biomérieux SA
• HESKA Corporation
• IDEXX Laboratories, Inc.
• ID.Vet, Neogen Corporation
• Qiagen N.V.
• Randox Laboratories Ltd
• Thermo Fisher Scientific Inc
• Virbac,
• Zoetis
LIST OF OTHER PLAYERS IN THE VALUE CHAIN(These players are not profiled in the report. The same will be included on request)
• Eurofins Technologies
• AusDiagnostics Pty, Ltd.
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Top player positioning
3.2.1. Top investment pockets
3.3. Porter's five forces analysis
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Thereat of new entrants
3.3.4. Threat of substitutes
3.3.5. Intensity of competitive rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Surge in ownership of companion animals
3.4.1.2. Rise in animal health expenditure
3.4.1.3. Increase in demand for pet insurance
3.4.2. Restraint
3.4.2.1. Lack of veterinary infrastructure facilities in underdeveloped nations
3.4.3. Opportunity
3.4.3.1. Surge in awareness related to animal healthcare
3.4.4. Impact Analysis
CHAPTER 4: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Immunodiagnostics
4.2.1. Key market trends and growth opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Molecular Diagnostics
4.3.1. Key market trends and growth opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Others
4.4.1. Key market trends and growth opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
CHAPTER 5: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Dogs
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Cats
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Others
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
CHAPTER 6: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. Market analysis, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. market size and forecast, by product type
6.2.2.1.2. U.S. market size and forecast, by application
6.2.2.2. Canada
6.2.2.2.1. Canada market size and forecast, by product type
6.2.2.2.2. Canada market size and forecast, by application
6.2.2.3. Mexico
6.2.2.3.1. Mexico market size and forecast, by product type
6.2.2.3.2. Mexico market size and forecast, by application
6.2.3. North America market size and forecast, by product type
6.2.4. North America market size and forecast, by application
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Market analysis, by country
6.3.2.1. Germany
6.3.2.1.1. Germany market size and forecast, by product type
6.3.2.1.2. Germany market size and forecast, by application
6.3.2.2. France
6.3.2.2.1. France market size and forecast, by product type
6.3.2.2.2. France market size and forecast, by application
6.3.2.3. UK
6.3.2.3.1. UK market size and forecast, by product type
6.3.2.3.2. UK market size and forecast, by application
6.3.2.4. Italy
6.3.2.4.1. Italy market size and forecast, by product type
6.3.2.4.2. Italy market size and forecast, by application
6.3.2.5. Rest of Europe
6.3.2.5.1. Rest of Europe market size and forecast, by product type
6.3.2.5.2. Rest of Europe market size and forecast, by application
6.3.3. Europe market size and forecast, by product type
6.3.4. Europe market size and forecast, by application
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Market analysis, by country
6.4.2.1. Japan
6.4.2.1.1. Japan market size and forecast, by product type
6.4.2.1.2. Japan market size and forecast, by application
6.4.2.3. China
6.4.2.3.1. China market size and forecast, by product type
6.4.2.3.2. China market size and forecast, by application
6.4.2.4. India
6.4.2.4.1. India market size and forecast, by product type
6.4.2.4.2. India market size and forecast, by application
6.4.2.5. Rest of Asia-Pacific
6.4.2.5.1. Rest of Asia-Pacific market size and forecast, by product type
6.4.2.5.2. Rest of Asia-Pacific market size and forecast, by application
6.4.3. Asia-Pacific market size and forecast, by product type
6.4.4. Asia-Pacific market size and forecast, by application
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. Market analysis, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil market size and forecast, by product type
6.5.2.1.2. Brazil market size and forecast, by application
6.5.2.2. Saudi Arabia
6.5.2.2.1. Saudi Arabia market size and forecast, by product type
6.5.2.2.2. Saudi Arabia market size and forecast, by application
6.5.2.3. South Africa
6.5.2.3.1. South Africa market size and forecast, by product type
6.5.2.3.2. South Africa market size and forecast, by application
6.5.2.4. Rest of LAMEA
6.5.2.4.1. Rest of LAMEA market size and forecast, by product type
6.5.2.4.2. Rest of LAMEA market size and forecast, by application
6.5.3. LAMEA market size and forecast, by product type
6.5.4. LAMEA market size and forecast, by application
CHAPTER 7: COMPANY PROFILES
7.1. bioMérieux SA
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.2. Heska Corporation
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.3. IDEXX Laboratories, Inc.
7.3.1. Company overview
7.3.2. Operating business segments
7.3.3. Product portfolio
7.3.1. Business performance
7.4. ID.Vet
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.5. Neogen Corporation
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.6. QIAGEN N.V.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments
7.7. Randox Laboratories Ltd
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Key strategic moves and developments
7.8. THERMO FISHER SCIENTIFIC INC
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.9. Virbac.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.10. Zoetis
7.10.1. Company overview
7.10.2. Operating business segments
7.10.3. Product portfolio
7.10.4. Business performance
TABLE 01. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2016–2026 ($MILLION)
TABLE 02. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY REGION, 2018–2026 ($MILLION)
TABLE 03. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 04. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHERS MARKET, BY REGION 2018–2026 ($MILLION)
TABLE 05. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY APPLICATION, 2016–2026 ($MILLION)
TABLE 06. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR DOGS, BY REGION, 2018–2026 ($MILLION)
TABLE 07. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATS, BY REGION, 2018–2026 ($MILLION)
TABLE 08. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2018–2026 ($MILLION)
TABLE 09. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 10. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 11. U.S. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 12. U.S. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 13. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 14. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 15. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 16. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 17. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 18. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 19. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 20. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 21. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 22. FRANCE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 23. FRANCE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 24. UK VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 25. UK VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 26. ITALY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 27. ITALY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 28. REST OF EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 29. REST OF EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 30. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 31. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 32. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 33. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 34. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 35. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 36. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 37. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 38. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 39. REST OF ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 40. REST OF ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 41. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 42. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 43. LAMEA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 44. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 45. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 46. SAUDI ARABIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 47. SAUDI ARABIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 48. SOUTH AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 49. SOUTH AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 50. REST OF LAMEA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 51. REST OF LAMEA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 52. LAMEA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 53. LAMEA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 54. BIOMÉRIEUX: COMPANY SNAPSHOT
TABLE 55. BIOMÉRIEUX: OPERATING SEGMENTS
TABLE 56. BIOMÉRIEUX: PRODUCT PORTFOLIO
TABLE 57. HESKA: COMPANY SNAPSHOT
TABLE 58. HESKA: PRODUCT SEGMENTS
TABLE 59. HESKA: PRODUCT PORTFOLIO
TABLE 60. IDEXX.: COMPANY SNAPSHOT
TABLE 61. IDEXX.: OPERATING SEGMENTS
TABLE 62. IDEXX.: PRODUCT PORTFOLIO
TABLE 63. ID.VET: COMPANY SNAPSHOT
TABLE 64. ID.VET: OPERATING SEGMENTS
TABLE 65. ID.VET: PRODUCT PORTFOLIO
TABLE 66. NEOGEN: COMPANY SNAPSHOT
TABLE 67. NEOGEN: OPERATING SEGMENTS
TABLE 68. NEOGEN: PRODUCT PORTFOLIO
TABLE 69. QIAGEN: COMPANY SNAPSHOT
TABLE 70. QIAGEN: OPERATING BUSINESS SEGMENTS
TABLE 71. QIAGEN: PRODUCT PORTFOLIO
TABLE 72. RANDOX: COMPANY SNAPSHOT
TABLE 73. RANDOX: OPERATING BUSINESS SEGMENTS
TABLE 74. RANDOX: PRODUCT PORTFOLIO
TABLE 75. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 76. THERMO FISHER SCIENTIFIC: OPERATING BUSINESS SEGMENTS
TABLE 77. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 78. VIRBAC: COMPANY SNAPSHOT
TABLE 79. VIRBAC: OPERATING SEGMENTS
TABLE 80. VIRBAC: PRODUCT PORTFOLIO
TABLE 81. ZOETIS: COMPANY SNAPSHOT
TABLE 82. ZOETIS: PRODUCT BUSINESS SEGMENTS
TABLE 83. ZOETIS: PRODUCT PORTFOLIO
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
